ANCA testing - New developments and clinical implications

被引：7

作者：

Ahmed, AEE

Peter, JB

Shoenfeld, YY

机构：

[1] Specialty Labs, Santa Monica, CA 90404 USA

[2] Tel Aviv Univ, Suckler Fac Med, Chaim Sheba Med Ctr, Dept Med,Res Unit Autoimmune Dis, IL-52621 Tel Hashomer, Israel

来源：

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY | 1998年 / 16卷 / 03期

关键词：

D O I：

10.1007/BF02737640

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：303 / 311

页数：9

共 50 条

[21] NEW DEVELOPMENTS IN IMPACT TESTING
BUCKNALL, CB
PLASTICS AND RUBBER, 1976, 1 (02): : 95 - 96
[22] New developments in microbial testing
Giese, J
FOOD TECHNOLOGY, 1998, 52 (01) : 79 - 80
[23] NEW DEVELOPMENTS IN TENSILE TESTING
TUIJNMAN, CAF
RHEOLOGICA ACTA, 1975, 14 (01) : 101 - 102
[24] NEW DEVELOPMENTS IN PREGNANCY TESTING
VANWEEMEN, B
GOVERDE, B
VANHELL, H
LEUVERING, J
SCHUURS, A
CONTRACEPTIVE DELIVERY SYSTEMS, 1982, 3 (3-4) : 358 - 358
[25] Recent developments in hardness testing and their implications for standardisation
Bell, T.J.
Thwaite, E.G.
CIRP Annals - Manufacturing Technology, 1999, 48 (01): : 449 - 452
[26] Recent developments in hardness testing and their implications for standardisation
Bell, TJ
Thwaite, EG
CIRP ANNALS 1999 - MANUFACTURING TECHNOLOGY, 1999, : 449 - 452
[27] CLINICAL IMPLICATIONS OF DEVELOPMENTS IN INVITRO FERTILIZATION
WOOD, C
DOWNING, B
TROUNSON, A
ROGERS, P
BRITISH MEDICAL JOURNAL, 1984, 289 (6450): : 978 - 980
[28] New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management
Saraff, Vrinda
Nadar, Ruchi
Hoegler, Wolfgang
PEDIATRIC DRUGS, 2020, 22 (02) : 113 - 121
[29] New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management
Vrinda Saraff
Ruchi Nadar
Wolfgang Högler
Pediatric Drugs, 2020, 22 : 113 - 121
[30] New developments in obsessive-compulsive disorder research: Implications for clinical management
Sasson, Y
Zohar, J
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 : 3 - 12

← 1 2 3 4 5 →